No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PODDInsulet Corporation | 20.15B | 286.49 | 49.57 | 22.07% | 9.76% | 17.79% | 1.52% | 1.17 |
| DXCMDexCom, Inc. | 27B | 69.24 | 48.76 | 11.34% | 15.96% | 26.44% | 2.34% | 1.23 |
| AHCOAdaptHealth Corp. | 1.44B | 10.64 | 17.44 | 1.9% | 2.81% | 4.93% | 16.36% | 1.35 |
| MODDModular Medical, Inc. | 36.82M | 0.47 | -0.93 | -276.23% | 0.05 | |||
| SENSSenseonics Holdings, Inc. | 297.04M | 7.27 | -2.91 | 0.37% | -209.21% | -82.83% | ||
| TNDMTandem Diabetes Care, Inc. | 1.43B | 21.07 | -14.33 | 25.74% | -20.2% | -152.95% | 0.35% | 1.80 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 192.56M | 345.28M | 529.64M | 1.06B | 2.45B | 2.97B | 3.2B | 3.26B |
| Revenue Growth % | - | 0.79% | 0.53% | 0.99% | 1.32% | 0.21% | 0.08% | 0.02% |
| Cost of Goods Sold | 162.9M | 285.2M | 440.7M | 898.6M | 2.01B | 2.55B | 2.52B | 2.58B |
| COGS % of Revenue | 0.85% | 0.83% | 0.83% | 0.85% | 0.82% | 0.86% | 0.79% | 0.79% |
| Gross Profit | 29.66M | 60.08M | 88.94M | 157.79M | 445.61M | 417.43M | 681.77M | 681.09M |
| Gross Margin % | 0.15% | 0.17% | 0.17% | 0.15% | 0.18% | 0.14% | 0.21% | 0.21% |
| Gross Profit Growth % | - | 1.03% | 0.48% | 0.77% | 1.82% | -0.06% | 0.63% | -0% |
| Operating Expenses | 693 | 1.23M | 59.56M | 86.44M | 220M | 227.01M | 1.28B | 417.36M |
| OpEx % of Revenue | 0% | 0% | 0.11% | 0.08% | 0.09% | 0.08% | 0.4% | 0.13% |
| Selling, General & Admin | 693 | 1.04M | 56.49M | 89.35M | 167.5M | 162.13M | 190.09M | 359.24M |
| SG&A % of Revenue | 0% | 0% | 0.11% | 0.08% | 0.07% | 0.05% | 0.06% | 0.11% |
| Research & Development | 310K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 0% | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 197.59K | 3.07M | -2.9M | 52.5M | 64.89M | 1.09B | 58.12M |
| Operating Income | -690 | -1.23M | 29.38M | 71.35M | 225.6M | 190.41M | -598.4M | 263.73M |
| Operating Margin % | -0% | -0% | 0.06% | 0.07% | 0.09% | 0.06% | -0.19% | 0.08% |
| Operating Income Growth % | - | -1786.99% | 24.81% | 1.43% | 2.16% | -0.16% | -4.14% | 1.44% |
| EBITDA | 27.82M | 49.38M | 91.94M | 153.79M | 483.66M | 613.85M | -177.81M | 629.07M |
| EBITDA Margin % | 0.14% | 0.14% | 0.17% | 0.15% | 0.2% | 0.21% | -0.06% | 0.19% |
| EBITDA Growth % | - | 0.78% | 0.86% | 0.67% | 2.14% | 0.27% | -1.29% | 4.54% |
| D&A (Non-Cash Add-back) | 27.82M | 50.61M | 62.57M | 82.44M | 258.05M | 423.44M | 420.59M | 365.33M |
| EBIT | -693 | 30.24M | 17.44M | -164.61M | 286.15M | 207.32M | -591.68M | 262.69M |
| Net Interest Income | 0 | 0 | -39.3M | -41.43M | -95.19M | -109.41M | -130.3M | -126.67M |
| Interest Income | 0 | 4.15M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 4.15M | 39.3M | 41.43M | 95.19M | 109.41M | 130.3M | 126.67M |
| Other Income/Expense | 0 | -8.85M | -51.24M | -277.39M | -34.65M | -92.51M | -125.38M | -127.71M |
| Pretax Income | -693 | 2.92M | -21.86M | -206.04M | 190.96M | 97.9M | -723.78M | 136.02M |
| Pretax Margin % | -0% | 0.01% | -0.04% | -0.2% | 0.08% | 0.03% | -0.23% | 0.04% |
| Income Tax | 0 | 829.81K | 739K | -11.96M | 32.81M | 24.77M | -49M | 41.24M |
| Effective Tax Rate % | 1% | 0.72% | 0.98% | 0.78% | 0.82% | 0.71% | 0.94% | 0.66% |
| Net Income | -693 | 2.09M | -21.34M | -161.63M | 156.18M | 69.32M | -678.89M | 90.42M |
| Net Margin % | -0% | 0.01% | -0.04% | -0.15% | 0.06% | 0.02% | -0.21% | 0.03% |
| Net Income Growth % | - | 3011.24% | -11.23% | -6.57% | 1.97% | -0.56% | -10.79% | 1.13% |
| Net Income (Continuing) | -693 | 24.34M | -22.6M | -194.09M | 158.15M | 73.13M | -674.78M | 94.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -34.09M | 2.87M | -26.96M | -74.04M | 4.78M | 6.6M | 8.21M | 6.97M |
| EPS (Diluted) | 0.00 | 0.07 | 0.17 | -1.23 | 0.67 | 0.50 | -5.31 | 0.61 |
| EPS Growth % | - | - | 1.54% | -8.24% | 1.54% | -0.25% | -11.62% | 1.11% |
| EPS (Basic) | 0.00 | 0.07 | 0.17 | -1.23 | 1.12 | 0.52 | -5.32 | 0.62 |
| Diluted Shares Outstanding | 31.25M | 31.25M | 72.38M | 52.49M | 133.03M | 138.99M | 134.42M | 135.53M |
| Basic Shares Outstanding | 31.25M | 31.25M | 72.38M | 52.49M | 126.31M | 134.18M | 134.16M | 133.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 119.82K | 1.11M | 181.41M | 363.25M | 670.06M | 585.31M | 649.02M | 755.79M |
| Cash & Short-Term Investments | 119.82K | 947.1K | 76.88M | 99.96M | 149.63M | 46.27M | 77.13M | 109.75M |
| Cash Only | 119.82K | 947.1K | 76.88M | 99.96M | 149.63M | 46.27M | 77.13M | 109.75M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 53.02M | 78.62M | 171.06M | 359.9M | 359.15M | 388.91M | 408.02M |
| Days Sales Outstanding | - | 56.04 | 54.18 | 59.11 | 53.52 | 44.13 | 44.36 | 45.67 |
| Inventory | 4.96M | 7.67M | 13.24M | 58.78M | 123.09M | 127.75M | 113.64M | 139.84M |
| Days Inventory Outstanding | 11.12 | 9.82 | 10.96 | 23.88 | 22.36 | 18.26 | 16.47 | 19.78 |
| Other Current Assets | 0 | -60.69M | 0 | 0 | 0 | 52.14M | 69.34M | 98.18M |
| Total Non-Current Assets | 190.79K | 253.02M | 365.12M | 1.45B | 4.58B | 4.63B | 3.86B | 3.73B |
| Property, Plant & Equipment | 35.57M | 61.6M | 63.56M | 110.47M | 546.34M | 622.01M | 637.53M | 618.36M |
| Fixed Asset Turnover | 5.41x | 5.61x | 8.33x | 9.56x | 4.49x | 4.78x | 5.02x | 5.27x |
| Goodwill | 38.63M | 202.44M | 266.79M | 998.81M | 3.51B | 3.55B | 2.72B | 2.68B |
| Intangible Assets | 0 | 0 | 0 | 116.06M | 202.23M | 162.77M | 130.16M | 105.55M |
| Long-Term Investments | 0 | -276.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -74.01M | 253.02M | 6.85M | 16.48M | 15.1M | 22.41M | 21.13M | 17.58M |
| Total Assets | 310.62K | 254.12M | 546.54M | 1.81B | 5.25B | 5.22B | 4.51B | 4.49B |
| Asset Turnover | 619.93x | 1.36x | 0.97x | 0.58x | 0.47x | 0.57x | 0.71x | 0.73x |
| Asset Growth % | - | 817.13% | 1.15% | 2.32% | 1.9% | -0.01% | -0.14% | -0% |
| Total Current Liabilities | 286.31K | 699.39K | 154.05M | 422.05M | 499.81M | 456.21M | 537M | 566.99M |
| Accounts Payable | 60.51K | 40.77K | 79.24M | 191.04M | 248.03M | 222.5M | 211.5M | 284.6M |
| Days Payables Outstanding | 0.14 | 0.05 | 65.63 | 77.6 | 45.06 | 31.81 | 30.65 | 40.27 |
| Short-Term Debt | 174.24K | 27.9M | 1.72M | 8.15M | 20M | 35M | 53.37M | 16.25M |
| Deferred Revenue (Current) | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | -9.95M | -27.9M | 20.3M | 126.37M | 43.19M | 19.86M | 14.68M | 33.55M |
| Current Ratio | 0.42x | 1.58x | 1.18x | 0.86x | 1.34x | 1.28x | 1.21x | 1.33x |
| Quick Ratio | -16.92x | -9.39x | 1.09x | 0.72x | 1.09x | 1.00x | 1.00x | 1.09x |
| Cash Conversion Cycle | - | 65.81 | -0.48 | 5.39 | 30.82 | 30.58 | 30.17 | 25.19 |
| Total Non-Current Liabilities | 54.91M | 7.88M | 458.27M | 1.11B | 2.68B | 2.61B | 2.5B | 2.34B |
| Long-Term Debt | 52.7M | 127.09M | 395.11M | 776.57M | 2.18B | 2.15B | 2.09B | 1.96B |
| Capital Lease Obligations | 0 | 172.47K | 233.14K | 0 | 120.18M | 108.34M | 108.28M | 104.91M |
| Deferred Tax Liabilities | 0 | 3.78M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -52.7M | -119.39M | 62.92M | 334.01M | 380.25M | 344M | 302.09M | 272.02M |
| Total Liabilities | 286.31K | 8.57M | 612.32M | 1.53B | 3.18B | 3.06B | 3.04B | 2.91B |
| Total Debt | 174.24K | 155.17M | 416.82M | 807M | 2.37B | 2.33B | 2.29B | 2.13B |
| Net Debt | 54.42K | 154.22M | 339.94M | 707.03M | 2.22B | 2.28B | 2.22B | 2.02B |
| Debt / Equity | - | 0.62x | - | 2.87x | 1.15x | 1.08x | 1.56x | 1.35x |
| Debt / EBITDA | 0.01x | 3.14x | 4.53x | 5.25x | 4.90x | 3.79x | - | 3.39x |
| Net Debt / EBITDA | 0.00x | 3.12x | 3.70x | 4.60x | 4.59x | 3.72x | - | 3.21x |
| Interest Coverage | - | -0.30x | 0.75x | 1.72x | 2.37x | 1.74x | -4.59x | 2.08x |
| Total Equity | -34.07M | 248.42M | -65.78M | 280.85M | 2.07B | 2.16B | 1.47B | 1.58B |
| Equity Growth % | - | 8.29% | -1.26% | 5.27% | 6.36% | 0.04% | -0.32% | 0.08% |
| Book Value per Share | -1.09 | 7.95 | -0.91 | 5.35 | 15.54 | 15.52 | 10.91 | 11.64 |
| Total Shareholders' Equity | 24.31K | 245.55M | -38.82M | 354.89M | 2.06B | 2.15B | 1.46B | 1.57B |
| Common Stock | 719 | 240.55M | 7K | 9K | 13K | 13K | 13K | 13K |
| Retained Earnings | -693 | 2.09M | -40.26M | -199.2M | -43.02M | 26.3M | -652.6M | -562.18M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -13.99M | -43.27M | -25.55M |
| Accumulated OCI | 0 | 0 | 1.43M | -4.41M | -2.35M | 8.69M | 4.36M | 2.25M |
| Minority Interest | -34.09M | 2.87M | -26.96M | -74.04M | 4.78M | 6.6M | 8.21M | 6.97M |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 45.93M | 68.43M | 60.42M | 195.63M | 275.68M | 373.87M | 480.67M | 541.84M |
| Operating CF Margin % | 0.24% | 0.2% | 0.11% | 0.19% | 0.11% | 0.13% | 0.15% | 0.17% |
| Operating CF Growth % | - | 0.49% | -0.12% | 2.24% | 0.41% | 0.36% | 0.29% | 0.13% |
| Net Income | -690 | 2.09M | 12.24M | -194.09M | 158.15M | 73.13M | -678.89M | 94.78M |
| Depreciation & Amortization | 27.82M | 50.61M | 11.28M | 82.44M | 258.05M | 351.18M | 420.59M | 365.33M |
| Stock-Based Compensation | 48.75K | 884K | 11.07M | 18.67M | 25.32M | 22.4M | 22.47M | 14.88M |
| Deferred Taxes | 0 | -2.88M | 895.3K | -21.1M | 22.38M | 18.04M | -62.59M | 32.05M |
| Other Non-Cash Items | 12.02M | 65.91M | 43.12M | 232.8M | -34.92M | 17.12M | 804.2M | 60.85M |
| Working Capital Changes | 690 | 429.32K | -18.19M | 76.91M | -153.31M | -108M | -25.11M | -26.06M |
| Change in Receivables | -3.04M | -21.34M | -11.81M | -29.52M | -29.69M | -209K | -28.86M | -26.22M |
| Change in Inventory | 1.14M | 2.31M | -14.26M | -19.43M | -14.92M | -6.3M | 15.53M | -28.07M |
| Change in Payables | 0 | -19.73K | 8.78M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -15.08M | -248.87M | -386K | -815.7M | -1.82B | -411.17M | -357.28M | -310.27M |
| Capital Expenditures | -6.85M | -9.95M | -21.33M | -39.76M | -203.31M | -391.42M | -337.46M | -306.06M |
| CapEx % of Revenue | 0.04% | 0.03% | 0.04% | 0.04% | 0.08% | 0.13% | 0.11% | 0.09% |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 280.51K | -238.92M | 20.38M | 0 | 0 | 0 | 0 | 5.32M |
| Cash from Financing | 119.82K | 251.33M | -13.89M | 643.15M | 1.6B | -66.05M | -92.53M | -198.95M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | -250M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | -573.96K | 1.51M | -70.84M | -34.92M | -75.68M | -15.88M | -11.48M | -19.08M |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | 39.08M | 58.48M | 39.09M | 155.88M | 72.37M | -17.56M | 143.2M | 235.78M |
| FCF Margin % | 0.2% | 0.17% | 0.07% | 0.15% | 0.03% | -0.01% | 0.04% | 0.07% |
| FCF Growth % | - | 0.5% | -0.33% | 2.99% | -0.54% | -1.24% | 9.16% | 0.65% |
| FCF per Share | 1.25 | 1.87 | 0.54 | 2.97 | 0.54 | -0.13 | 1.07 | 1.74 |
| FCF Conversion (FCF/Net Income) | -66277.97x | 32.80x | -2.83x | -1.21x | 1.77x | 5.39x | -0.71x | 5.99x |
| Interest Paid | 0 | 0 | 23.07M | 35.77M | 73.63M | 108.89M | 126.23M | 122.07M |
| Taxes Paid | 0 | 0 | 1.32M | 7.48M | 14.79M | 14.95M | 14.76M | 14.14M |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | 1.95% | -23.37% | -150.31% | 13.31% | 3.28% | -37.46% | 5.94% |
| Return on Invested Capital (ROIC) | - | -0.5% | 6.51% | 8.48% | 6.41% | 3.27% | -11.05% | 5.43% |
| Gross Margin | 15.4% | 17.4% | 16.79% | 14.94% | 18.15% | 14.05% | 21.3% | 20.89% |
| Net Margin | -0% | 0.6% | -4.03% | -15.3% | 6.36% | 2.33% | -21.21% | 2.77% |
| Debt / Equity | - | 0.62x | - | 2.87x | 1.15x | 1.08x | 1.56x | 1.35x |
| Interest Coverage | - | -0.30x | 0.75x | 1.72x | 2.37x | 1.74x | -4.59x | 2.08x |
| FCF Conversion | -66277.97x | 32.80x | -2.83x | -1.21x | 1.77x | 5.39x | -0.71x | 5.99x |
| Revenue Growth | - | 79.31% | 53.4% | 99.45% | 132.35% | 21.02% | 7.73% | 1.9% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Respiratory Health | - | - | - | - | 651.15M |
| Respiratory Health Growth | - | - | - | - | - |
| Diabetes | - | 541.21M | 687.09M | 660.04M | - |
| Diabetes Growth | - | - | 26.96% | -3.94% | - |
| Health Care, Other | - | - | 261.62M | 301.15M | - |
| Health Care, Other Growth | - | - | - | 15.11% | - |
| Supplies To Home | 145.62M | - | - | - | - |
| Supplies To Home Growth | - | - | - | - | - |
AdaptHealth Corp. (AHCO) has a price-to-earnings (P/E) ratio of 17.4x. This is roughly in line with market averages.
AdaptHealth Corp. (AHCO) reported $2.85B in revenue for fiscal year 2024. This represents a 1380% increase from $192.6M in 2017.
AdaptHealth Corp. (AHCO) grew revenue by 1.9% over the past year. Growth has been modest.
Yes, AdaptHealth Corp. (AHCO) is profitable, generating $80.2M in net income for fiscal year 2024 (2.8% net margin).
AdaptHealth Corp. (AHCO) has a return on equity (ROE) of 5.9%. This is below average, suggesting room for improvement.
AdaptHealth Corp. (AHCO) generated $213.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.